Obinutuzumab in hematologic malignancies: Lessons learned to date

Published 2015 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Obinutuzumab in hematologic malignancies: Lessons learned to date
Authors
Keywords
Obinutuzumab, Rituximab, CD20, CLL, NHL, Type II antibody
Journal
CANCER TREATMENT REVIEWS
Volume 41, Issue 9, Pages 784-792
Publisher
Elsevier BV
Online
2015-07-14
DOI
10.1016/j.ctrv.2015.07.003

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.